Tofacitinib for Refractory Immune-Related Colitis from PD-1 Therapy
Khashayar Esfahani, Marie Hudson, Gerald Batist
Abstract
Tofacitinib for Autoimmune Colitis from Anti-PD1 Tofacitinib is a JAK inhibitor that decreases cytokine production. In a woman with autoimmune colitis from the administration of pembrolizumab to tr...
Topics & Concepts
MedicineTofacitinibRefractory (planetary science)ColitisUlcerative colitisImmune systemImmunologyInternal medicineRheumatoid arthritisAstrobiologyPhysicsDiseaseMicroscopic ColitisInflammatory Bowel DiseaseCancer Immunotherapy and Biomarkers